EQL Pharma AB Income Statement

Financials in millions SEK. Fiscal year is April - March.

Millions SEK. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	432.66	373.52	264.17	259.91	409.75
Revenue	432.66	373.52	264.17	259.91	409.75
Revenue Growth (YoY)	15.83%	41.39%	1.64%	-36.57%	128.73%
Cost of Revenue	269.82	217.56	149.12	144.06	314.02
Gross Profit	162.84	155.95	115.05	115.85	95.73
Selling, General & Admin	102.92	78.46	70.8	59.79	48.16
Research & Development	14.33	11.26	12.09	15.14	9.13
Other Operating Expenses	-3.1	-1.14	-0.46	-0.41	-0.4
Operating Expenses	114.16	88.58	82.43	74.51	56.9
Operating Income	48.69	67.37	32.62	41.34	38.84
Interest Expense	-30.49	-12.34	-5.73	-2.37	-2.87
Interest & Investment Income	-	0.01	0.2	0	-
Other Non Operating Income (Expenses)	0.01	-0.68	-0	-	0
EBT Excluding Unusual Items	18.21	54.36	27.08	38.97	35.97
Gain (Loss) on Sale of Investments	-	-	1.53	-	-
Pretax Income	18.21	54.36	28.6	38.97	35.97
Income Tax Expense	5.67	11.23	5.9	8.05	4.42
Net Income	12.54	43.12	22.71	30.92	31.55
Net Income to Common	12.54	43.12	22.71	30.92	31.55
Net Income Growth	-70.93%	89.93%	-26.57%	-1.99%	204.32%
Shares Outstanding (Basic)	30	29	29	29	29
Shares Outstanding (Diluted)	30	30	30	30	29
Shares Change (YoY)	0.92%	0.34%	0.91%	1.59%	-
EPS (Basic)	0.42	1.48	0.78	1.06	1.09
EPS (Diluted)	0.42	1.44	0.76	1.04	1.09
EPS Growth	-70.83%	89.47%	-26.92%	-4.19%	204.32%
Free Cash Flow	22.92	-30.78	-12.36	27.16	41.2
Free Cash Flow Per Share	0.76	-1.03	-0.41	0.92	1.42
Gross Margin	37.64%	41.75%	43.55%	44.57%	23.36%
Operating Margin	11.25%	18.04%	12.35%	15.90%	9.48%
Profit Margin	2.90%	11.54%	8.60%	11.90%	7.70%
Free Cash Flow Margin	5.30%	-8.24%	-4.68%	10.45%	10.05%
EBITDA	69.96	75.68	38.81	47.37	40.54
EBITDA Margin	16.17%	20.26%	14.69%	18.23%	9.89%
D&A For EBITDA	21.27	8.31	6.19	6.03	1.7
EBIT	48.69	67.37	32.62	41.34	38.84
EBIT Margin	11.25%	18.04%	12.35%	15.90%	9.48%
Effective Tax Rate	31.13%	20.66%	20.62%	20.65%	12.28%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.